Today's Date
Research Study of ATG and Rituximab in Renal Transplantation
(
RESTARRT
)
ITN Protocol #:
ITN039ST
Branded Name:
RESTARRT
ClinicalTrials.Gov ID:
NCT01318915Treatment Protocol #:
ATG / Rituximab
Therapeutic Area:
Transplantation
Current Status:
Complete
Summary:
Immunosuppression With Antithymocyte Globulin, Rituximab, Tacrolimus, Mycophenolate Mofetil and Sirolimus, Followed by Withdrawal of Immunosuppression, in Living-donor Renal Transplant Recipients
Clinical Operations Associate Director
ITN Clinical Trials Physician
NIAID Project Manager
Rho Scientist
Study Personnel:
